Published in
Wiley, Hepatology Research, 7(52), p. 630-640, 2022
DOI: 10.1111/hepr.13771
Links
Tools
Comparison of atezolizumab plus bevacizumab and lenvatinib in terms of efficacy and safety as primary systemic chemotherapy for hepatocellular carcinoma
Journal article published in 2022 by
Kazuki Maesaka,
Ryotaro Sakamori 
,
Ryoko Yamada,
Akira Doi,
Yuki Tahata,
Masanori Miyazaki,
Kazuyoshi Ohkawa ,
Eiji Mita,
Sadaharu Iio,
Yasutoshi Nozaki,
Takayuki Yakushijin,
Yasuharu Imai,
Takahiro Kodama ,
Hayato Hikita ,
Tomohide Tatsumi
and other authors.
,
Ryoko Yamada,
Akira Doi,
Yuki Tahata,
Masanori Miyazaki,
Kazuyoshi Ohkawa ,
Eiji Mita,
Sadaharu Iio,
Yasutoshi Nozaki,
Takayuki Yakushijin,
Yasuharu Imai,
Takahiro Kodama ,
Hayato Hikita ,
Tomohide Tatsumi
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 